Effect of CYP2C19 polymorphism on the safety and efficacy of omeprazole in Japanese patients with recurrent reflux oesophagitis.
Ohkusa T, Maekawa T, Arakawa T, Nakajima M, Fujimoto K, Hoshino E, Mitachi Y, Hamada S, Mine T, Kawahara Y, Nagai T, Aoyama N, Yoshida N, Tadokoro K, Chida N, Konda Y, Seno H, Shimatani T, Inoue M, Sato N.
Ohkusa T, et al. Among authors: hoshino e.
Aliment Pharmacol Ther. 2005 Jun 1;21(11):1331-9. doi: 10.1111/j.1365-2036.2005.02486.x.
Aliment Pharmacol Ther. 2005.
PMID: 15932363
Free article.
Clinical Trial.